Clinical trial

Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis

NCT04595045

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-01-24

PhasePHASE3

Study timeline

Study start (actual)2019-01-24Date precision: day

Registry last updated2022-08-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Botulinum toxin type A infiltrationsDRUG

Sponsors & collaborators

Aránzazu Vázquez Docelead sponsor

Mapped research locations

MadridSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04595045 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.